Swiss National Bank »

Kymera Therapeutics shares owned by Swiss National Bank

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Swiss National Bank from 13F filings

Historical chart of Swiss National Bank investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Swiss National Bank

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.2M 80k 40.20
2023-12-31 $1.8M 71k 25.46
2023-09-30 $1.1M 79k 13.90
2023-06-30 $1.5M 66k 22.99
2023-03-31 $2.3M 77k 29.63
2022-12-31 $2.0M 81k 24.96
2022-09-30 $1.7M 80k 21.77
2022-06-30 $1.5M 79k 19.70
2022-03-31 $2.8M 67k 42.32
2021-12-31 $3.9M 62k 63.50
2021-09-30 $3.6M 61k 58.74
2021-06-30 $1.2M 25k 48.50
2021-03-31 $979k 25k 38.85
2020-12-31 $1.6M 25k 61.98